← Back to Search

Aromatherapy for Pain

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 7 minutes
Awards & highlights

Study Summary

This trial tests if aromatherapy can reduce anxiety and pain in kids with cancer during medical procedures.

Who is the study for?
This trial is for pediatric oncology patients aged between 4 and 18 who are scheduled for port access. It's not suitable for children with asthma, reactive airway disease, allergies to the aromatherapy ingredients (lavender, bergamot, sweet orange, ylang ylang), those already using aromatherapy for pain procedures or those unable to report pain or anxiety levels.Check my eligibility
What is being tested?
The study tests if STILL QuickTAB Medipack blended scent aromatherapy can reduce anxiety and pain in kids during port access. The effectiveness of this specific blend of essential oils will be measured by changes in patient-reported scores.See study design
What are the potential side effects?
Potential side effects may include allergic reactions to the essential oil ingredients used in the aromatherapy such as skin irritation or respiratory issues especially in children with a history of asthma or allergies.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 7 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 7 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effect of aromatherapy on post patient anxiety scores
Secondary outcome measures
Effect of aromatherapy on post patient port pain scores
Other outcome measures
Aromatherapy effect according to age

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: AromatherapyExperimental Treatment1 Intervention
Patients will be given STILL QuickTAB Medipack blended scent aromatherapy in addition to standard supportive measures, which include numbing cream, Child Life support, distraction, caregiver hold, or any combination of these, based on patient preference.
Group II: Control GroupActive Control1 Intervention
Participants will be offered standard supportive measures, which include numbing cream, Child Life support, distraction, caregiver hold, or any combination of these, based on patient preference.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,403 Previous Clinical Trials
17,342,694 Total Patients Enrolled
42 Trials studying Pain
5,261 Patients Enrolled for Pain
Annette Nasr, PhDStudy DirectorStanford University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age criteria for enrolling in this experiment more than 25 years?

"Eligibility requirements for this clinical trial specify that candidates must range in age from 4 to 18 years old."

Answered by AI

Are there any vacancies in the current research program?

"Clinicaltrials.gov reports that this specific medical research is no longer accepting patients, as the trial was most recently edited on January 23rd 2023. Although enrollment has closed for this investigation, there are 355 additional clinical trials currently enrolling participants."

Answered by AI

Who is eligible to be part of this scientific exploration?

"This trial is looking for 115 minors aged between 4 and 18 who suffer from fear or anxiety. To be eligible, they must meet the following conditions: fall within the specified age range, require port access with or without lab draw, and have a diagnosis of oncology, neuro-oncology, or stem cell transplant."

Answered by AI
~43 spots leftby Aug 2024